We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Baker Hughes
BKR
$64.3B
| $995K | ﹤0.01% |
46,044
+32,713
| +245% | +$745K |
|
1552
XBiotech
XBIT
$71M
| $993K | ﹤0.01% |
57,807
-3,279
| -5% | -$61.2K |
|
|
ISBC
1553
DELISTED
Investors Bancorp, Inc.
ISBC
| $993K | ﹤0.01% |
67,626
+15,389
| +29% | +$199K |
|
1554
Veeco
VECO
$3.07B
| $990K | ﹤0.01% |
47,752
-4,720
| -9% | -$98.1K |
|
|
SBNY
1555
DELISTED
Signature Bank
SBNY
| $984K | ﹤0.01% |
4,371
-28,015
| -87% | -$5.52M |
|
|
LGTY
1556
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $983K | ﹤0.01% |
47,488
-15,104
| -24% | -$302K |
|
1557
Editas Medicine
EDIT
$453M
| $982K | ﹤0.01% |
23,370
+6,988
| +43% | +$398K |
|
1558
Penumbra
PEN
$12.9B
| $980K | ﹤0.01% |
3,665
-2,925
| -44% | -$755K |
|
1559
Innovative Industrial Properties
IIPR
$1.67B
| $974K | ﹤0.01% |
5,407
-733
| -12% | -$141K |
|
1560
TechTarget
TTGT
$271M
| $974K | ﹤0.01% |
14,025
+16
| +0.1% | +$1.24K |
|
|
NSTG
1561
DELISTED
NanoString Technologies, Inc.
NSTG
| $973K | ﹤0.01% |
14,809
+1,963
| +15% | +$138K |
|
1562
Nelnet
NNI
$4.48B
| $972K | ﹤0.01% |
13,366
-579
| -4% | -$42K |
|
1563
Sutro Biopharma
STRO
$415M
| $971K | ﹤0.01% |
4,267
+2,766
| +184% | +$656K |
|
1564
PagerDuty
PD
$915M
| $969K | ﹤0.01% |
24,080
+14,384
| +148% | +$657K |
|
1565
Viemed Healthcare
VMD
$353M
| $966K | ﹤0.01% |
95,420
+10,085
| +12% | +$94.9K |
|
|
ALLK
1566
DELISTED
Allakos
ALLK
| $965K | ﹤0.01% |
8,408
+6,507
| +342% | +$822K |
|
|
TVTY
1567
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $965K | ﹤0.01% |
43,244
+23,019
| +114% | +$528K |
|
1568
Wyndham Hotels & Resorts
WH
$5.38B
| $964K | ﹤0.01% |
+13,810
| New | +$882K |
|
1569
Intercorp Financial Services
IFS
$6.35B
| $962K | ﹤0.01% |
32,176
| – | – |
|
1570
United Bankshares
UBSI
$6.61B
| $960K | ﹤0.01% |
24,893
+11,586
| +87% | +$425K |
|
1571
UDR
UDR
$12B
| $956K | ﹤0.01% |
22,043
+776
| +4% | +$32.1K |
|
1572
Matador Resources
MTDR
$6.51B
| $951K | ﹤0.01% |
+40,566
| New | +$809K |
|
1573
Genworth Financial
GNW
$3.7B
| $947K | ﹤0.01% |
285,164
| – | – |
|
1574
Gentherm
THRM
$1.27B
| $947K | ﹤0.01% |
12,778
| – | – |
|
1575
Compañía de Cervecerías Unidas
CCU
$2.22B
| $946K | ﹤0.01% |
53,514
-69,777
| -57% | -$1.21M |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.